HIV
Conference Coverage
COVID-19 disruptions ‘life threatening’ for people with HIV
Conference Coverage
HIV does not appear to worsen COVID-19 outcomes
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD.
Commentary
‘COVID-sorting’: How we decide whom to get close to and whom to avoid
Patients are making calculations about managing physical distancing using their own internal formulas, said Dr. Jack Drescher.
Article
ID dermatology: Advancements, but new challenges, over 50 years
One of the biggest wins for ID dermatology over the last 5 decades has been herpes. It started with the approval of acyclovir in 1981.
Supplements
Infectious Diseases Board Review: Menopause in Women Living With HIV
Conference Coverage
MCC response varies based on immunosuppression type, especially CLL
News from the FDA/CDC
FDA approves pomalidomide for Kaposi sarcoma
Conference Coverage
Evolocumab safe, well-tolerated in HIV+ patients
PCSK9 inhibition may play a major role in curbing markedly increased cardiovascular risk in people living with HIV.
Conference Coverage
Should ART for HIV be initiated prior to tuberculosis testing results?
Conference Coverage
Bone density slow to rebound after lactation in women with HIV
Conference Coverage
A case of neutrophilic eccrine hidradenitis attributed to HIV treatment
The most common causes of NEH are hematologic malignancies and some of the chemotherapeutic agents used in treating them.